WWW.KONF.X-PDF.RU
- , ,
 


Pages:     | 1 |   ...   | 5 | 6 || 8 |

, 03.02.02 ...

-- [ 7 ] --

.., .., .. 10.

// . 2000. 1. . 114.

.., .., .., .., .., 11.

.., .., .. , // . 2013. . 58. 3. . 37-42.

.. 12.

in vivo: . ..... . : 03.02.02 / . - , 2013. 20 .

.., .., .., .., .., 13.

.. : in vivo // . 2011. 6. . 14 .. // 14.

. . 1973. . . 54-64.

.. 15.

MDCK: . ..... . :

03.00.06/ . , 2007 - 21 .

.., .., .., .., .. 16.

// . 2007. . 52. 4. . 22-26.

.. : ..... - . :

17.

03.00.06/ . , 2001. 34 .

.., Voeten J.T., Teley L.C., .., .., 18.

.., .., van den Bosch H., Heldens J.G., .. // , . 2011. 4. . 29-36.

.., .., .., .. 19.

/17/ /99/145 (H1N1) . 2183672 . 2002.- 17.

.., .., .., .., .., 20.

.., .., .., .. // . 2003. . 48. 4. . 26-29.

.., .., .., .. 21.

/17//04/6 (H3N2) . 2315101 20.07.2007.

.., .., .., .., .., 22.

.. A//134/17/7/57 (H2N2) , // . 2005. 2. . 14-18.

.., .., Voeten J.T.M., Teley L.C.P., Drieszenvan der Cruijsen 23.

S.K.M., Heldens J.G.M., van den Bosch J.F., .. // . 2010. 6. . 41-47.

.., .., .., .., .., 24.

.., .., .. ( ) // . 2010. . 10. 4. . 240-248.

.., .., .., .., .., 25.

.., .., .. // . 2002. . 2. 3. .

49-57.

.. 26.

: . .. - . : 03.00.06, 03.00.04/ . , 1995. 85 .., .., .., .., ..

27.

, // . 2006. 5 . 38-41.

.., .., .., .. 28.

/17//2009/38 (H1N1) . 2413765 16.09.09. . 2011.7.

.. 29.

( ):

. - . : 03.00.06/ , 1966 43 .

.., .., .. 30.

, - 2 // . . 1972. . 143-149.

.., .., .., .., .., 31.

.., .., .. //538/74 // . . 1977. . 19. . 128-137.

3.3.2.1758-03. 32.

(. 28.09.2003).

.. : 33.

// . 2010. . 10. 4. . 249-255.

.. : 34.

, , // . 2012. . 57. 3. . 4-9.

.., .., .., .., .., .., 35.

.., .. // . 1991. . 36. 3. . 194 .., .. 36.

// . 2004. . 6. 6. . 487-492.

.., .., .. , 37.

// . 1980. 4. . 408.

.., .., .., .., .., ..

38.

- // . 1997. 6. . 271-275.

.., .., .., .., ..

39.

- // . 1997. 5. . 212-215.

.., .., .., .., .., ..

40.

T- // .

2011. . 56. 5. . 15-21.

.., .., .., .., .., .., 41.

.., .. // . 2002. 12. . 24-28.

.., .., .., .., .., ..

42.

- - , A (H5N2) // . 2012. . 57. 1. . 38-42.

.. SPSS 15: . 2011. 43.

-: . 416 .

., . . 2003. : -. 44.

101 .

.., .., .., .. 45.

// . 2005. . 4. 3. .

148-149.

.., .., .., .., .., .. ts- // . . II 12 - 14 2012 . 2012. . 333 - 335.

.., .., .., .., .., 47.

.., .. // . 2006. . 8. 4.

. 511 - 516.

708 23.08.2010 " 48.

".

.., .., .., .. - 49.

, // . 2002. . 47. 4. . 27 .., .., .., .., .., 50.

.., .. // . 1989. 5. . 547-553.

.., - .., .., .., .., 51.

.., .., .., .., ..

// . 2013. . 71. 4. . 74-81.

.., .., .., .. 52.

, // . 2011. . 1. 3. . 44-50.

.., .., .., .., .. 53.

"" (H5N2) // . 2013. 6. . 31-35.

.., .., .., .., ..

54.

//07/2009 (H1N1) // . . 2011. 6. . 72-76.

.., .., .., .., .., 55.

.. () 299/80 , . SU 1040788 A. . 30.10.1986. 40. 1986.

.., .., .., .., .. 56.

(H5N1) . . . . 03. 06.2009 . ., 2009. 13 .

.., .., .., .., .., 57.

.., .. . : , , , , 45 2425 2012 , . . .., .. , 2012. . 28-38.

.., .., .., - .., .., 58.

.. A/Singapore/57 (H2N2) // XVI - - . 20 2013. - , 2013. . 421 .., .., .., .., .., 59.

.., .. , / /20/99 (H1N1), // . 2012. . 12. 4. c.57-59.

.., .., Auewarakul P., Suptawiwat O., .. 60.

// , . 2014. 4. c. 3-9.

.., .., - .., .., ..

61.

, , ( ) // . 2014. 11 ( 6). c. 1311-1315.

.., .., .., .., .., 62.

.., .., .., .., .. , // . 2014. . 3. 76. . 70-83.

N003224/01-270313. . 63.

. 2013.

.., .., .., .., .., .., 64.

.. // . 1972. 5. . 582-586.

Air G.M. Influenza neuraminidase // Influenza Other Respir Viruses. 2012. V. 6. 4. 65.

p. 245-56.

66. Ali A., Avalos R.T., Ponimaskin E., Nayak D.P. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein // J Virol. 2000. V. 74. 18. p. 8709-8719.

67. Altman P.L., Katz D.D., eds. Inbred and genetically defined strains of laboratory animals. Part 2: hamster, Guinea pig, rabbit, and chicken. 1979, Federation of American Societies for Experimental Biology. 320 p.

68. Area E., Martin-Benito J., Gastaminza P., Torreira E., Valpuesta J.M., Carrascosa J.L., Ortin J.

3D structure of the influenza virus polymerase complex: localization of subunit domains // Proc Natl Acad Sci U S A. 2004. V. 101. 1. p. 308-313.

69. Arnold K., Bordoli L., Kopp J., Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling // Bioinformatics. 2006. V. 22. 2. p. 195-201.

70. Asahi-Ozaki Y., Yoshikawa T., Iwakura Y., Suzuki Y., Tamura S., Kurata T., Sata T. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus // J Med Virol. 2004. V. 74. 2. p. 328-335.

71. Askonas B.A., McMichael A.J., Webster R.G. The immune response to influenza viruses and the problem of protection against infection // In: Beare AS, ed. Basic and Applied Influenza Research. Boca Raton, FL: CRC Press. 1982. p. 159-188.

72. Aytay S.,Schulze I.T. Single amino acid substitutions in the hemagglutinin can alter the host range and receptor binding properties of H1 strains of influenza A virus // J Virol. 1991. V.

65. 6. p. 3022-3028.

73. Azoulay-Dupuis E., Lambre C.R., Soler P., Moreau J., Thibon M. Lung alterations in guineapigs infected with influenza virus // J Comp Pathol. 1984. V. 94. 2. p. 273-283.

74. Bahir I., Fromer M., Prat Y., Linial M. Viral adaptation to host: a proteome-based analysis of codon usage and amino acid preferences // Mol Syst Biol. 2009. V. 5. p. 311.

75. Baron S.,Jensen K.E. Evidence for genetic interaction between non-infectious and infectious influenza A viruses // J Exp Med. 1955. V. 102. 6. p. 677-697.

76. Baudin F., Petit I., Weissenhorn W., Ruigrok R.W. In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein // Virology. 2001. V. 281. 1. p.

102-108.

77. Baum L.G.,Paulson J.C. The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity // Virology. 1991. V. 180. 1. p. 10-15.

78. Beare A.S. Laboratory characteristics of attenuated influenza viruses // Bull World Health Organ. 1969. V. 41. 3. p. 595-598.

79. Beare A.S., Maassab H.F., Tyrrell D.A., Slepuskin A.N., Hall T.S. A comparative study of attenuated influenza viruses // Bull World Health Organ. 1971. V. 44. 5. p. 593-598.

80. Belser J.A., Katz J.M., Tumpey T.M. The ferret as a model organism to study influenza A virus infection // Dis Model Mech. 2011. V. 4. 5. p. 575-579.

81. Besse F.,Ephrussi A. Translational control of localized mRNAs: restricting protein synthesis in space and time // Nat Rev Mol Cell Biol. 2008. V. 9. 12. p. 971-980.

82. Biswas S.K.,Nayak D.P. Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1 // J Virol. 1994. V. 68. 3. p. 1819-1826.

83. Both G.W., Shi C.H., Kilbourne E.D. Hemagglutinin of swine influenza virus: a single amino acid change pleiotropically affects viral antigenicity and replication // Proc Natl Acad Sci U S A. 1983. V. 80. 22. p. 6996-7000.

84. Brice A.R.,Lazaridis T. Structure and dynamics of a fusion peptide helical hairpin on the membrane surface: comparison of molecular simulations and NMR // J Phys Chem B. 2014.

V. 118. 17. p. 4461-4470.

85. Brown T.A., Murphy B.R., Radl J., Haaijman J.J., Mestecky J. Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans // J Clin Microbiol. 1985. V. 22. 2. p. 259-264.

86. Bullough P.A., Hughson F.M., Skehel J.J., Wiley D.C. Structure of influenza haemagglutinin at the pH of membrane fusion // Nature. 1994. V. 371. 6492. p. 37-43.

87. Burgui I., Aragon T., Ortin J., Nieto A. PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes // J Gen Virol. 2003. V. 84. Pt 12. p. 3263-74.

88. Burmeister W.P., Ruigrok R.W., Cusack S. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid // EMBO J. 1992. V. 11. 1. p. 49Burnet F.M.,Lind P.E. Reactivation of heat inactivated influenza virus by recombination // Aust J Exp Biol Med Sci. 1954. V. 32. 2. p. 133-143.

90. Burns C.C., Shaw J., Campagnoli R., Jorba J., Vincent A., Quay J., Kew O. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region // J Virol. 2006. V. 80. 7. p. 3259-3272.

91. Bushnell R.V., Tobin J.K., Long J., Schultz-Cherry S., Chaudhuri A.R., Nara P.L., Tobin G.J.

Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein // Virol J. 2010. V. 7. 1. p. 200.

92. Cady S.D., Schmidt-Rohr K., Wang J., Soto C.S., Degrado W.F., Hong M. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers // Nature. 2010. V. 463. 7281. p. 689-692.

93. Callard R.E. Specific in vitro antibody response to influenza virus by human blood lymphocytes // Nature. 1979. V. 282. 5740. p. 734-736.

94. Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) // Cell. 1982. V. 31. 2 Pt 1. p. 417Chanturiya A.N., Basanez G., Schubert U., Henklein P., Yewdell J.W., Zimmerberg J. PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes // J Virol. 2004. V. 78. 12. p. 6304-6312.

96. Chen M.W., Cheng T.J., Huang Y., Jan J.T., Ma S.H., Yu A.L., Wong C.H., Ho D.D. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses // Proc Natl Acad Sci U S A. 2008. V. 105. 36. p. 13538-13543.

97. Chen Z., Zhou H., Jin H. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response // Vaccine. 2010. V. 28. 24. p. 4079-4085.

98. Chen Z., Zhou H., Kim L., Jin H. The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets // J Virol. 2012. V. 86. 5. p. 2780-2786.

99. Chiba J., Otokawa M., Nakagawa M., Egashira Y. Serological studies on the major histocompatibility complex of new inbred strains of the guinea pig // Microbiol Immunol. 1978. V. 22. 9. p. 545-555.

100. Chu C.M., Tian S.F., Ren G.F., Zhang Y.M., Zhang L.X., Liu G.Q. Occurrence of temperaturesensitive influenza A viruses in nature // J Virol. 1982. V. 41. 2. p. 353-359.

101. Chu C.M., Wei B.Y., Tian S.F., Ren G.F. Host dependence of naturally occurring temperaturesensitive influenza A viruses and location of their genetic lesions // Virus Res. 1992. V. 22.

3. p. 207-214.

102. Chung B.K.,Lee D.Y. Computational codon optimization of synthetic gene for protein expression // BMC Syst Biol. 2012. V. 6. p. 134.

103. Cohen M., Hurtado-Ziola N., Varki A. ABO blood group glycans modulate sialic acid recognition on erythrocytes // Blood. 2009. V. 114. 17. p. 3668-3676.

104. Coleman J.R. The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages // Virol J. 2007. V. 4. . p. 9.

105. Coleman J.R., Papamichail D., Skiena S., Futcher B., Wimmer E., Mueller S. Virus attenuation by genome-scale changes in codon pair bias // Science. 2008. V. 320. 5884. p. 1784Colman P.M. Influenza virus neuraminidase: structure, antibodies, and inhibitors // Protein Sci.

1994. V. 3. 10. p. 1687-1696.

107. Colman P.M., Varghese J.N., Laver W.G. Structure of the catalytic and antigenic sites in influenza virus neuraminidase // Nature. 1983. V. 303. 5912. p. 41-44.

Couch R.B., Kasel J.A. Immunity to influenza in man // Annu Rev Microbiol. 1983. 108.

V. 37. p. 529-549.

109. Cox R.J., Brokstad K.A., Ogra P. Influenza virus: immunity and vaccination strategies.

Comparison of the immune response to inactivated and live, attenuated influenza vaccines // Scand J Immunol. 2004. V. 59. 1. p. 1-15.

110. Cox R.J., Brokstad K.A., Zuckerman M.A., Wood J.M., Haaheim L.R., Oxford J.S. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination // Vaccine. 1994. V. 12. 11. p. 993-999.

111. Cretescu L., Beare A.S., Schild G.C. Formation of antibody to matrix protein in experimental human influenza A virus infections // Infect Immun. 1978. V. 22. 2. p. 322-327.

112. D'Andrea L., Pinto R.M., Bosch A., Musto H., Cristina J. A detailed comparative analysis on the overall codon usage patterns in hepatitis A virus // Virus Res. 2011. V. 157. 1. p.

19-24.

113. Das S.R., Puigbo P., Hensley S.E., Hurt D.E., Bennink J.R., Yewdell J.W. Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain // PLoS Pathog. 2010. V. 6. 11. p. e1001211.

114. de Boer G.F., Back W., Osterhaus A.D. An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species // Arch Virol. 1990. V. 115. 1p. 47-61.

115. Dong J., Matsuoka Y., Maines T.R., Swayne D.E., O'Neill E., Davis C.T., Van-Hoven N., Balish A., Yu H.J., Katz J.M., Klimov A., Cox N., Li D.X., Wang Y., Guo Y.J., Yang W.Z., Donis R.O., Shu Y.L. Development of a new candidate H5N1 avian influenza virus for prepandemic vaccine production // Influenza Other Respi Viruses. 2009. V. 3. 6. p.

287-295.

116. Els M.C., Air G.M., Murti K.G., Webster R.G., Laver W.G. An 18-amino acid deletion in an influenza neuraminidase // Virology. 1985. V. 142. 2. p. 241-247.

117. Epstein S.L. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature // J Infect Dis. 2006. V. 193. 1. p. 49-53.

118. Fan J., Liang X., Horton M.S., Perry H.C., Citron M.P., Heidecker G.J., Fu T.M., Joyce J., Przysiecki C.T., Keller P.M., Garsky V.M., Ionescu R., Rippeon Y., Shi L., Chastain M.A., Condra J.H., Davies M.E., Liao J., Emini E.A., Shiver J.W. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys // Vaccine. 2004. V. 22. 23-24. p. 2993-3003.

119. Fanning T.G., Reid A.H., Taubenberger J.K. Influenza A virus neuraminidase: regions of the protein potentially involved in virus-host interactions // Virology. 2000. V. 276. 2. p. 417-423.

120. Fechter P., Mingay L., Sharps J., Chambers A., Fodor E., Brownlee G.G. Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding // J Biol Chem. 2003. V. 278. 22. p. 20381-20388.

121. Feng J.Q., Mozdzanowska K., Gerhard W. Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype // J Virol. 2002. V. 76. 3. p. 1369-1378.

Fu M. Codon usage bias in herpesvirus // Arch Virol. 2010. V. 155. 3. p. 391-396.

122.

Fuglsang A. Codon optimizer: a freeware tool for codon optimization // Protein Expr Purif. 123.

2003. V. 31. 2. p. 247-249.

124. Gambaryan A.S., Lomakina N.F., Boravleva E.Y., Kropotkina E.A., Mashin V.V., Krasilnikov I.V., Klimov A.I., Rudenko L.G. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine). // Influenza.Other Respi.Viruses. 2012. V. 6. 3. p. 188-195.

125. Gambaryan A.S., Marinina V.P., Tuzikov A.B., Bovin N.V., Rudneva I.A., Sinitsyn B.V., Shilov A.A., Matrosovich M.N. Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs // Virology. 1998. V. 247. 2. p. 170-177.

126. Gambaryan A.S., Robertson J.S., Matrosovich M.N. Effects of egg-adaptation on the receptorbinding properties of human influenza A and B viruses // Virology. 1999. V. 258. 2. p. 232-239.

127. Gambaryan A.S., Tuzikov A.B., Piskarev V.E., Yamnikova S.S., Lvov D.K., Robertson J.S., Bovin N.V., Matrosovich M.N. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'sialyl(N-acetyllactosamine) // Virology. 1997. V. 232. 2. p. 345-350.

128. Gao Y., Zhang Y., Shinya K., Deng G., Jiang Y., Li Z., Guan Y., Tian G., Li Y., Shi J., Liu L., Zeng X., Bu Z., Xia X., Kawaoka Y., Chen H. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host // PLoS Pathog. 2009. V. 5. 12. p. e1000709.

129. Gibbs J.S., Malide D., Hornung F., Bennink J.R., Yewdell J.W. The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function // J Virol. 2003. V. 77. 13. p. 7214-24.

130. Gimsa U., Grotzinger I., Gimsa J. Two evolutionary strategies of influenza viruses to escape host non-specific inhibitors: alteration of hemagglutinin or neuraminidase specificity // Virus Res. 1996. V. 42. 1-2. p. 127-35.

131. Glaser L., Stevens J., Zamarin D., Wilson I.A., Garcia-Sastre A., Tumpey T.M., Basler C.F., Taubenberger J.K., Palese P. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity // J Virol. 2005. V. 79. 17. p.

11533-11536.

132. Gocnik M., Fislova T., Mucha V., Sladkova T., Russ G., Kostolansky F., Vareckova E.

Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection // J Gen Virol. 2008. V. 89. Pt 4. p. 958Gocnik M., Fislova T., Sladkova T., Mucha V., Kostolansky F., Vareckova E. Antibodies specific to the HA2 glycopolypeptide of influenza A virus haemagglutinin with fusioninhibition activity contribute to the protection of mice against lethal infection // J Gen Virol. 2007. V. 88. Pt 3. p. 951-955.

134. Gomez M.M., Tort L.F., Volotao Ede M., Recarey R., Moratorio G., Musto H., Leite J.P., Cristina J. Analysis of human P[4]G2 rotavirus strains isolated in Brazil reveals codon usage bias and strong compositional constraints // Infect Genet Evol. 2011. V. 11. 3. p. 580-586.

135. Gotlieb T., Hirst G.K. The experimental production of combination forms of virus. VI.

Reactivation of influenza viruses after inactivation by ultraviolet light // Virology. 1956. V. 2. 2. p. 235-248.

136. Graf M., Deml L., Wagner R. Codon-optimized genes that enable increased heterologous expression in mammalian cells and elicit efficient immune responses in mice after vaccination of naked DNA // Methods Mol Med. 2004. V. 94. p. 197-210.

137. Grant E., Wu C., Chan K.F., Eckle S., Bharadwaj M., Zou Q.M., Kedzierska K., Chen W.

Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses // Immunol Cell Biol. 2013. V. 91. 2. p. 184-194.

138. Grote A., Hiller K., Scheer M., Munch R., Nortemann B., Hempel D.C., Jahn D. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host // Nucleic Acids Res.

2005. V. 33. suppl 2. p. W526-W531.

139. Gulati U., Hwang C.C., Venkatramani L., Gulati S., Stray S.J., Lee J.T., Laver W.G., Bochkarev A., Zlotnick A., Air G.M. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98) // J Virol. 2002. V. 76. 23. p. 12274Gupta V., Earl D.J., Deem M.W. Quantifying influenza vaccine efficacy and antigenic distance // Vaccine. 2006. V. 24. 18. p. 3881-3888.

141. Ha Y., Stevens D.J., Skehel J.J., Wiley D.C. H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes // EMBO J. 2002. V. 21. 5. p. 865-875.

142. Hale B.G., Randall R.E., Ortin J., Jackson D. The multifunctional NS1 protein of influenza A viruses // J Gen Virol. 2008. V. 89. Pt 10. p. 2359-76.

143. Hamada M., Kiryu H., Sato K., Mituyama T., Asai K. Prediction of RNA secondary structure using generalized centroid estimators // Bioinformatics. 2009. V. 25. 4. p. 465-473.

144. Hanaoka K., Pritchett T.J., Takasaki S., Kochibe N., Sabesan S., Paulson J.C., Kobata A. 4-Oacetyl-N-acetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig alpha 2-macroglobulins, potent inhibitors of influenza virus infection // J Biol Chem. 1989. V. 264. 17. p. 9842-9849.

145. Hartley C.A., Reading P.C., Ward A.C., Anders E.M. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice // Arch Virol. 1997. V. 142. 1. p. 75-88.

146. Hatfield G.W., Roth D.A. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering // Biotechnol Annu Rev. 2007. V. 13. p. 27-42.

147. Hay A.J., Lomniczi B., Bellamy A.R., Skehel J.J. Transcription of the influenza virus genome // Virology. 1977. V. 83. 2. p. 337-355.

148. He F., Prabakaran M., Tan Y., Indira K., Kumar S.R., Kwang J. Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus // BMC Microbiol. 2013. V. 13. p. 219.

149. He X.S., Holmes T.H., Zhang C., Mahmood K., Kemble G.W., Lewis D.B., Dekker C.L., Greenberg H.B., Arvin A.M. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines // J Virol. 2006. V. 80. 23. p.

11756-11766.

150. Healey D.G., Agha N., Turk J.L. Behaviour of guinea pig T cells stimulated by antigen, alloantigen and mitogen // Int Arch Allergy Appl Immunol. 1988. V. 87. 2. p. 134-142.

Helenius A. Unpacking the incoming influenza virus // Cell. 1992. V. 69. 4. p. 577Hensley S.E., Das S.R., Bailey A.L., Schmidt L.M., Hickman H.D., Jayaraman A., Viswanathan K., Raman R., Sasisekharan R., Bennink J.R., Yewdell J.W. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift // Science. 2009. V. 326. 5953. p. 734-736.

153. Hiromatsu K., Dascher C.C., Sugita M., Gingrich-Baker C., Behar S.M., LeClair K.P., Brenner M.B., Porcelli S.A. Characterization of guinea-pig group 1 CD1 proteins // Immunology. 2002. V. 106. 2. p. 159-172.

154. Hirst G.K., Gotlieb T. The experimental production of combination forms of virus. V.

Alterations in the virulence of neurotropic influenza virus as a result of mixed infection // Virology. 1955. V. 1. 2. p. 221-235.

155. Hoffmann E., Krauss S., Perez D., Webby R., Webster R.G. Eight-plasmid system for rapid generation of influenza virus vaccines // Vaccine. 2002. V. 20. 25-26. p. 3165-3170.

156. Hoffmann E., Lipatov A.S., Webby R.J., Govorkova E.A., Webster R.G. Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines // Proc Natl Acad Sci U S A. 2005. V. 102. 36. p. 12915-12920.

157. Hoffmann E., Mahmood K., Chen Z., Yang C.F., Spaete J., Greenberg H.B., Herlocher M.L., Jin H., Kemble G. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66 // J Virol. 2005. V. 79. 17. p. 11014-11021.

Holm L. Codon usage and gene expression // Nucleic Acids Res. 1986. V. 14. 7. p.

158.

3075-3087.

Holman W.L. Spontaneous Infection in the Guinea-Pig // J Med Res. 1916. V. 35. 2. 159.

p. 151-185.

160. Huber V.C., Lynch J.M., Bucher D.J., Le J., Metzger D.W. Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections // J Immunol. 2001.

V. 166. 12. p. 7381-7388.

161. Hutchinson E.C., von Kirchbach J.C., Gog J.R., Digard P. Genome packaging in influenza A virus // J Gen Virol. 2010. V. 91. Pt 2. p. 313-328.

162. Ichinohe T., Iwasaki A., Hasegawa H. Innate sensors of influenza virus: clues to developing better intranasal vaccines // Expert Rev Vaccines. 2008. V. 7. 9. p. 1435-1445.

163. Imai M., Sugimoto K., Okazaki K., Kida H. Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin // Virus Res. 1998. V. 53. 2. p. 129-139.

164. Influenza Research Database; Available from: http://www.fludb.org. Accessed on: 1.07.2014.

165. Ingolotti M., Kawalekar O., Shedlock D.J., Muthumani K., Weiner D.B. DNA vaccines for targeting bacterial infections // Expert Rev Vaccines. 2010. V. 9. 7. p. 747-763.

166. Isakova-Sivak I., Chen L.M., Matsuoka Y., Voeten J.T., Kiseleva I., Heldens J.G., den Bosch H., Klimov A., Rudenko L., Cox N.J., Donis R.O. Genetic bases of the temperature-sensitive

phenotype of a master donor virus used in live attenuated influenza vaccines:

A/Leningrad/134/17/57 (H2N2) // Virology. 2011. V. 412. 2. p. 297-305.

167. Isin B., Doruker P., Bahar I. Functional motions of influenza virus hemagglutinin: a structurebased analytical approach // Biophys J. 2002. V. 82. 2. p. 569-581.

168. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species // Virology. 1997. V. 227. 2. p. 493-499.

169. Ito T., Suzuki Y., Takada A., Kawamoto A., Otsuki K., Masuda H., Yamada M., Suzuki T., Kida H., Kawaoka Y. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection // J Virol. 1997. V. 71. 4. p. 3357-3362.

170. Jegerlehner A., Schmitz N., Storni T., Bachmann M.F. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity // J Immunol. 2004. V. 172. 9. p. 5598-5605.

171. Jiang Y., Yu K., Zhang H., Zhang P., Li C., Tian G., Li Y., Wang X., Ge J., Bu Z., Chen H.

Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector // Antiviral Res. 2007. V. 75. 3. p. 234-241.

172. Jin H., Lu B., Zhou H., Ma C., Zhao J., Yang C.F., Kemble G., Greenberg H. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60 // Virology. 2003. V. 306. 1. p. 18-24.

173. Katz J.M., Naeve C.W., Webster R.G. Host cell-mediated variation in H3N2 influenza viruses // Virology. 1987. V. 156. 2. p. 386-395.

174. Kauffman C.A., Schiff G.M., Phair J.P. Influenza in ferrets and guinea pigs: effect on cellmediated immunity // Infect Immun. 1978. V. 19. 2. p. 547-552.

175. Kaverin N.V., Finskaya N.N., Rudneva I.A., Gitelman A.K., Kharitonenkov I.G., Smirnov Y.A. Studies on the genetic basis of human influenza A virus adaptation to mice: degrees of virulence of reassortants with defined genetic content // Arch Virol. 1989. V. 105. 1-2.

p. 29-37.

176. Kawaoka Y., Krauss S., Webster R.G. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics // J Virol. 1989. V. 63. 11. p.

4603-4608.

177. Kiefer F., Arnold K., Kunzli M., Bordoli L., Schwede T. The SWISS-MODEL Repository and associated resources // Nucleic Acids Res. 2009. V. 37. p. D387-92.

178. Kim M.S.,Sin J.I. Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model // Immunology. 2005. V. 116. 2. p. 255-266.

179. Kim S., Jang J.E., Yu J.R., Chang J. Single mucosal immunization of recombinant adenovirusbased vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection // Vaccine. 2010. V. 28. 22. p. 3801-3808.

180. Kiseleva I., Dubrovina I., Bazhenova E., Fedorova E., Larionova N., Rudenko L. Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains // Vaccine. 2012. V. 30. 51. p. 7395-7399.

181. Kiseleva I., Klimov A., Su Q., Szymkowiak C., Toner T.J., Kwan W.-S., Rudenko L., Shaw A.R., Youil R. Role of individual genes of the A/Leningrad/134/17/57 (H2N2) cold-adapted donor strain in manifestation of the temperature-sensitive phenotype of reassortant influenza A viruses // In: Proceedings of Options for the Control of Influenza V. Okinawa, Japan, 6-9 October, 2003. 2004. p. 547-550.

182. Kiseleva I.V., Voeten J.T., Teley L.C., Larionova N.V., Drieszen-van der Cruijsen S.K., Basten S.M., Heldens J.G., van den Bosch H., Rudenko L.G. PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus // J Gen Virol. 2010. V. 91. Pt 4. p. 931-937.

183. Kobasa D., Kodihalli S., Luo M., Castrucci M.R., Donatelli I., Suzuki Y., Suzuki T., Kawaoka Y. Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase // J Virol. 1999. V. 73. 8. p. 6743-6751.

184. Kochs G., Garcia-Sastre A., Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein // J Virol. 2007. V. 81. 13. p. 7011-7021.

185. Kreijtz J.H., de Mutsert G., van Baalen C.A., Fouchier R.A., Osterhaus A.D., Rimmelzwaan G.F. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus // J Virol. 2008. V. 82. 11. p. 5161Krizanova O., Rathova V. Serum inhibitors of myxoviruses // Curr Top Microbiol Immunol. 186.

1969. V. 47. p. 125-51.

187. Kuznetcova S., Isakova-Sivak I., Petukhova G., Losev I., Rudenko L., Naikhin A. Effect of ts mutations in polymerase genes of influenza A virus on its virulence, immunogenicity, and protective efficacy in a mouse model // Options for the control of influenza VIII: proceedings of the 8th International Conference on Options for the Control of Influenza, Cape Town, South Africa 5-10 September 2013. 2013. p. 288.

188. Kuznetcova V., Isakova-Sivak I., Kuznetcova S., Rudenko L. Evaluation of immunogenicity and cross-reactivity of influenza A viruses with different receptor-binding specificity in a mouse model // Options for the control of influenza VIII: proceedings of the 8th International Conference on Options for the Control of Influenza, Cape Town, South Africa 5-10 September 2013. 2013. p. 302.

189. Lamb R.A., Zebedee S.L., Richardson C.D. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface // Cell. 1985. V. 40. 3. p.

627-633.

190. Lang V., Marjuki H., Krauss S.L., Webby R.J., Webster R.G. Different incubation temperatures affect viral polymerase activity and yields of low-pathogenic avian influenza viruses in embryonated chicken eggs // Arch Virol. 2011. V. 156. 6. p. 987-994.

191. Larionova N., Kiseleva I., Dubrovina I., Bazhenova E., Rudenko L. Peculiarities of reassortment of coldadapted influenza A master donor virus with viruses possessed avian origin HA and NA H5N1 // Influenza Other Respi Viruses. 2011. V. 5. Suppl.1. p. 346Larionova N., Kiseleva I., Isakova-Sivak I., Rekstin A., Dubrovina I., Bazhenova E., Ross T.M., Swayne D.E., Gubareva L., Tsvetnitsky V., Fedorova E., Doroshenko E.V., Rudenko L.

Live Attenuated Influenza Vaccines against Highly Pathogenic H5N1 avian Influenza:

Development and Preclinical Characterization // Journal of Vaccines & Vaccination 2013. V. 4. 8.

193. Lauring A.S., Jones J.O., Andino R. Rationalizing the development of live attenuated virus vaccines // Nat Biotechnol. 2010. V. 28. 6. p. 573-579.

194. Lee J.T.,Air G.M. Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10 // Virology. 2002. V. 300. 2. p. 255-268.

195. Lee L.Y., Ha do L.A., Simmons C., de Jong M.D., Chau N.V., Schumacher R., Peng Y.C., McMichael A.J., Farrar J.J., Smith G.L., Townsend A.R., Askonas B.A., Rowland-Jones S., Dong T. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals // J Clin Invest. 2008. V. 118. 10. p. 3478-3490.

196. Lee P.S., Ohshima N., Stanfield R.L., Yu W., Iba Y., Okuno Y., Kurosawa Y., Wilson I.A.

Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus // Nat Commun. 2014. V. 5. p. 3614.

197. Leigh M.W., Connor R.J., Kelm S., Baum L.G., Paulson J.C. Receptor specificity of influenza virus influences severity of illness in ferrets // Vaccine. 1995. V. 13. 15. p. 1468-73.

198. LeVine A.M., Hartshorn K., Elliott J., Whitsett J., Korfhagen T. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection // Am J Physiol Lung Cell Mol Physiol. 2002. V. 282. 3. p. L563-72.

199. LeVine A.M., Whitsett J.A., Hartshorn K.L., Crouch E.C., Korfhagen T.R. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo // J Immunol. 2001. V. 167. 10. p. 5868-73.

200. Li K.B., Zhang X.G., Ma J., Jia X.J., Wang M., Dong J., Zhang X.M., Xu H., Shu Y.L. [Codon optimization of the H5N1 influenza virus HA gene gets high expression in mammalian cells] // Bing Du Xue Bao. 2008. V. 24. 2. p. 101-105.

201. Li M.L., Rao P., Krug R.M. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits // EMBO J. 2001. V. 20. 8. p. 2078-2086.

202. Lin D., Lan J., Zhang Z. Structure and function of the NS1 protein of influenza A virus // Acta Biochim Biophys Sin (Shanghai). 2007. V. 39. 3. p. 155-162.

203. Liu C., Eichelberger M.C., Compans R.W., Air G.M. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding // J Virol. 1995. V. 69.

2. p. 1099-1106.

204. Liu J., Stevens D.J., Haire L.F., Walker P.A., Coombs P.J., Russell R.J., Gamblin S.J., Skehel J.J. Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957 // Proc Natl Acad Sci U S A. 2009. V. 106. 40. p. 17175-17180.

205. Liu Y., Lou Z., Bartlam M., Rao Z. Structure-function studies of the influenza virus RNA polymerase PA subunit // Sci China C Life Sci. 2009. V. 52. 5. p. 450-458.

206. Londo D.R., Davis A.R., Nayak D.P. Complete nucleotide sequence of the nucleoprotein gene of influenza B virus // J Virol. 1983. V. 47. 3. p. 642-648.

207. Long J., Bushnell R.V., Tobin J.K., Pan K., Deem M.W., Nara P.L., Tobin G.J. Evolution of H3N2 influenza virus in a guinea pig model // PLoS One. 2011. V. 6. 7. p. e20130.

208. Lowen A.C., Mubareka S., Steel J., Palese P. Influenza virus transmission is dependent on relative humidity and temperature // PLoS Pathog. 2007. V. 3. 10. p. 1470-1476.

209. Lowen A.C., Mubareka S., Tumpey T.M., Garcia-Sastre A., Palese P. The guinea pig as a transmission model for human influenza viruses // Proc Natl Acad Sci U S A. 2006. V.

103. 26. p. 9988-9992.

210. Luo G., Chung J., Palese P. Alterations of the stalk of the influenza virus neuraminidase:

deletions and insertions // Virus Res. 1993. V. 29. 2. p. 141-153.



Pages:     | 1 |   ...   | 5 | 6 || 8 |
 

:

QX 06.02.02 , , , : , ...

(OVIBOS MOSCHATUS ZIMMERMANN, 1780) 03.02.08 : . . ., . . 2015 .. 1. -...

03.02.08 ( ) : ...

06.02.02 , , , : ...

14.02.01 : , ...

˨ (COLUBRIDAE) : , , 03.02.08 () ( ) : , .. 2015 1. ...

( . ) 03.02.14 : ..., .. 1. ...

- Stevia rebaudiana (Bertoni) Hemsley 06.01.05 ...

: 03.02.08 () : , .. 1. ...

: 03.02.08 , .. 2015 , . .. 5 1. . 19...

- 14.01.11 : . . 2015 1. 13 ...

06.02.03 : , ...

(SORBUS L.) 03.02.01 : ..., ... .. 2014 .. 4 1. .. 8 ...

- - CERASUS MILL. : 06.01.05. ...

- -1 , 03.01.03 ...

03.02.07 06.01.05 ...

14.02.02 : ...

( ) 25.00.36 ( ) - - 201...

03.01.00 : -. , , ... .. ...

13.00.01 , ...







 
<<     |    
2016 www.konf.x-pdf.ru - - , ,

, .
, , , , 1-2 .